These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1255 related items for PubMed ID: 16312177

  • 1. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B, Riek M, Holmes B, Grange S.
    Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
    [Abstract] [Full Text] [Related]

  • 2. Single daily doses of saquinavir achieve HIV-inhibitory concentrations when combined with baby-dose ritonavir.
    Kurowski M, Müller M, Donath F, Mrozikiewicz M, Möcklinghoff C.
    Eur J Med Res; 1999 Mar 26; 4(3):101-4. PubMed ID: 10085276
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and tolerability profile of twice-daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers.
    Kurowski M, Sternfeld T, Sawyer A, Hill A, Möcklinghoff C.
    HIV Med; 2003 Apr 26; 4(2):94-100. PubMed ID: 12702129
    [Abstract] [Full Text] [Related]

  • 4. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
    Parrillo-Campiglia S, Ercoli MC, Umpierrez O, Rodríguez P, Márquez S, Guarneri C, Estevez-Parrillo FT, Laurenz M, Estevez-Carrizo FE.
    Clin Ther; 2009 Oct 26; 31(10):2224-32. PubMed ID: 19922893
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of tenofovir disoproxil fumarate and ritonavir-boosted saquinavir mesylate administered alone or in combination at steady state.
    Chittick GE, Zong J, Blum MR, Sorbel JJ, Begley JA, Adda N, Kearney BP.
    Antimicrob Agents Chemother; 2006 Apr 26; 50(4):1304-10. PubMed ID: 16569845
    [Abstract] [Full Text] [Related]

  • 6. Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals.
    Veldkamp AI, van Heeswijk RP, Mulder JW, Meenhorst PL, Schreij G, van der Geest S, Lange JM, Beijnen JH, Hoetelmans RM.
    J Acquir Immune Defic Syndr; 2001 Aug 01; 27(4):344-9. PubMed ID: 11468422
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.
    Autar RS, Ananworanich J, Apateerapong W, Sankote J, Hill A, Hirschel B, Cooper D, Lange J, Phanuphak P, Ruxrungtham K, Burger D.
    J Antimicrob Chemother; 2004 Oct 01; 54(4):785-90. PubMed ID: 15329366
    [Abstract] [Full Text] [Related]

  • 8. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW, Aikman MS, Werts E, Seabolt J, Haeusler JM.
    Clin Ther; 2009 Nov 01; 31(11):2722-34. PubMed ID: 20110014
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun 01; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
    Chompootaweep S, Poonsrisawat J, Xumseang P.
    J Med Assoc Thai; 2006 Sep 01; 89 Suppl 3():S79-85. PubMed ID: 17722305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C, Smith P, Morrison R, Riek M, Patel A, Schmitt C, Morcos PN, Zhang X.
    Addict Biol; 2009 Jul 01; 14(3):321-7. PubMed ID: 19523046
    [Abstract] [Full Text] [Related]

  • 15. Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice daily.
    Boffito M, Maitland D, Dickinson L, Back D, Hill A, Fletcher C, Moyle G, Nelson M, Gazzard B, Pozniak A.
    J Antimicrob Chemother; 2005 Apr 01; 55(4):542-5. PubMed ID: 15722388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb 01; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 18. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG.
    Clin Ther; 2009 Aug 01; 31(8):1796-803. PubMed ID: 19808138
    [Abstract] [Full Text] [Related]

  • 19. Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers.
    Ruane PJ, Luber AD, Wire MB, Lou Y, Shelton MJ, Lancaster CT, Pappa KA, COL10053 Study Team.
    Antimicrob Agents Chemother; 2007 Feb 01; 51(2):560-5. PubMed ID: 17088488
    [Abstract] [Full Text] [Related]

  • 20. Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study).
    Lamotte C, Landman R, Peytavin G, Mentre F, Gerbe J, Brun-Vezinet F, Boue F, Spiridon G, Valantin MA, Michelet C, Farinotti R, Yeni P.
    Antivir Ther; 2004 Apr 01; 9(2):247-56. PubMed ID: 15134187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.